<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/5935">
    <title>DSpace Community:</title>
    <link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/5935</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13226" />
        <rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13225" />
        <rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13118" />
        <rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13117" />
      </rdf:Seq>
    </items>
    <dc:date>2026-11-18T05:53:49Z</dc:date>
  </channel>
  <item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13226">
    <title>Occurrence of deranged liver enzymes among patients with rheumatoid arthritis treated with methotrexate</title>
    <link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13226</link>
    <description>Title: Occurrence of deranged liver enzymes among patients with rheumatoid arthritis treated with methotrexate
Authors: Yadhury, S.; Kalki, P.; Kamshana, K.; Diluxcy, R.; Narani, A.
Abstract: Background and objective&#xD;
Methotrexate is the anchor disease-modifying anti-rheumatic drug for rheumatoid arthritis, but&#xD;
elevations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) require clinical&#xD;
review and monitoring. This study determined the occurrence of deranged liver enzymes and associated&#xD;
factors among methotrexate-treated patients with rheumatoid arthritis.&#xD;
Methods&#xD;
A hospital-based descriptive cross-sectional study was conducted among 221 adults receiving&#xD;
methotrexate for at least six months at the Rheumatology Clinic, Teaching Hospital, Jaffna. Data were&#xD;
collected using an interviewer-administered questionnaire and a clinical-record extraction form.&#xD;
Deranged liver enzymes were defined as ALT or AST exceeding 1.5 times the upper limit of normal in&#xD;
any of the three most recent consecutive reports available at the time of data collection. Categorical and&#xD;
continuous variables were analyzed using the Chi-square/Fisher's exact test and Mann–Whitney U test,&#xD;
respectively, with p&lt;0.05 indicating statistical significance.&#xD;
Results&#xD;
Deranged liver enzymes were identified in 20 participants (9.0%). Participants were predominantly&#xD;
female (85.5%); median age was 57 years (IQR 48–65), median weekly methotrexate dose was 10 mg&#xD;
(IQR 7.5–12.5), and median treatment duration was 5 years (IQR 2–7). Oral traditional medicine use&#xD;
was associated with deranged liver enzymes (21.7% among users versus 7.6% among non-users;&#xD;
p=0.042). Age, sex, alcohol use, concomitant anti-rheumatic therapy, methotrexate dose and treatment&#xD;
duration were not significantly associated.&#xD;
Conclusions&#xD;
Approximately one in eleven methotrexate-treated patients had deranged liver enzymes. Concomitant&#xD;
traditional medicine use was the only identified associated factor. Medication reconciliation and&#xD;
evaluation of alternative causes should accompany routine transaminase monitoring; causation cannot&#xD;
be inferred from this cross-sectional study.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13225">
    <title>Knowledge, attitude and practice towards triple whammy drug interaction and associated socio-demographic and work-related factors among pharmacists and nurses working at Teaching and Base Hospitals in Jaffna District</title>
    <link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13225</link>
    <description>Title: Knowledge, attitude and practice towards triple whammy drug interaction and associated socio-demographic and work-related factors among pharmacists and nurses working at Teaching and Base Hospitals in Jaffna District
Authors: Vogini, T.; Athana, K.; Shanthiya, Y.; Kalki, P.; Sathiyamoorthy, K.
Abstract: Background &amp; Objective: The “Triple Whammy (TW), the concurrent use of diuretics, renin–&#xD;
angiotensin–aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs (NSAIDs),&#xD;
increases the risk of acute kidney injury. Evidence on the knowledge, attitude, and practice (KAP)&#xD;
regarding TW among healthcare professionals in Sri Lanka is limited. This study assessed the&#xD;
knowledge, attitude, and practice (KAP) regarding TW drug interactions and examined their association&#xD;
with sociodemographic and work-related factors among registered pharmacists and nurses working at&#xD;
the Teaching Hospital and Base Hospitals in the Jaffna District.&#xD;
Methods: A descriptive cross-sectional survey was conducted among registered pharmacists and nurses&#xD;
working in cardiology and general wards at the Teaching Hospital and all four Base Hospitals in the&#xD;
Jaffna District. The calculated sample size was 385. The total number of eligible registered pharmacists&#xD;
and nurses was 144. As the accessible population was smaller than the calculated sample size, all&#xD;
eligible and available participants were invited to participate. Data were collected using a validated selfadministered&#xD;
questionnaire covering sociodemographic characteristics, work-related factors, and&#xD;
knowledge, attitude, and practice regarding triple whammy drug interactions. Data were analyzed using&#xD;
descriptive statistics to summarize participant characteristics and KAP levels and inferential statistics to&#xD;
examine the associations between sociodemographic and work-related factors and KAP using IBM&#xD;
SPSS Statistics, version 19.0.&#xD;
Results: A total of 130 pharmacists and nurses participated in the study, giving a response rate of&#xD;
91.5%. Of the participants, 36.2% were pharmacists and 63.8% were nurses. Overall, knowledge and&#xD;
attitudes towards TW were moderate, while practice was suboptimal. Only 53.8% were aware of TW,&#xD;
and 30.0% and 24.0% correctly identified the ACEI/diuretic/NSAID and ARB/diuretic/NSAID&#xD;
combinations, respectively. Although 65.4% felt capable of identifying TW interactions, 61.5% did not&#xD;
routinely screen for them, 62.3% did not provide counselling on avoiding inappropriate NSAID use and&#xD;
69.2% did not regularly update their knowledge. Higher knowledge and attitude scores were associated&#xD;
with younger age, pharmacist profession, bachelor’s qualification, and participation in continuous&#xD;
professional development (p&lt;0.05). Better practice was associated with bachelor’s qualification and&#xD;
continuous professional development (CPD) participation (p≤0.035).&#xD;
Conclusions: Pharmacists and nurses demonstrated moderate knowledge and positive attitudes towards&#xD;
TW but inadequate clinical practices. Strengthening CPD, targeted training, and interprofessional&#xD;
collaboration is essential to improve medication safety and prevent TW-related acute kidney injury.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13118">
    <title>Adherence, Knowledge to Epilepsy Medication and their Associated Factors Among Caregivers of Epileptic Children Followed up at the Paediatric Clinic at TH, Jaffna</title>
    <link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13118</link>
    <description>Title: Adherence, Knowledge to Epilepsy Medication and their Associated Factors Among Caregivers of Epileptic Children Followed up at the Paediatric Clinic at TH, Jaffna
Authors: Thenuka, K.; Kalki, P.; Nilukshika, U.; Saranja, N.; Sanchayan, K.
Abstract: Epilepsy affects both adults and children and requires long-term medication control, with antiepileptic drugs as the first-line therapy. Good adherence to anti-epileptic medication (AEM) is essential for optimal treatment outcomes, particularly in children who may not require lifelong treatment. Caregiver awareness and knowledge play a critical role, as non-adherence to AEM has become a significant concern. This hospital-based descriptive cross-sectional study aimed to assess caregiver knowledge and medication adherence among caregivers of children with epilepsy attending the Paediatric Clinic at Teaching Hospital Jaffna. A total of 127 caregivers aged over 18 years, caring for children under 14 years with epilepsy, participated in the study, with a response rate of 97%. Data were collected using a knowledge questionnaire (score range: 0–13), numerical, and the MARS-5 (Parent Version) adherence scale (score range: 6–30), categorized into good and poor adherence. Statistical analysis included Chi-square or Fisher’s exact tests, Mann–Whitney U, and Kruskal–Wallis tests, with significance set at p ≤ 0.05. Most caregivers were parents (96%). The mean caregiver knowledge score was moderate (8.43/13). Good adherence was significantly associated with higher knowledge scores, regular clinic attendance, fewer seizure episodes, family history of epilepsy, parental factors, and awareness of medication side effects. Higher knowledge levels were associated with being married, having a middle household income, a better understanding of epilepsy, and awareness of AEM side effects. The findings highlight the need for ongoing caregiver education and consistent support from healthcare professionals to ensure effective epilepsy management in children.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13117">
    <title>Prevalence of propranolol and pizotifen use and their side effects among migraine patients at Teaching Hospital, Jaffna</title>
    <link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/13117</link>
    <description>Title: Prevalence of propranolol and pizotifen use and their side effects among migraine patients at Teaching Hospital, Jaffna
Authors: Parkavi, R.; Kalki, P.; Kishajiny, I.; Kajanitha, K.; Ajantha, K.
Abstract: Introduction: Migraine is a unilateral headache accompanied by nausea, vomiting, photophobia and phonophobia. Propranolol and pizotifen are widely used in migraine prevention but their side effects (SE) often influence the therapeutic outcomes Objectives: To estimate the prevalence of propranolol and pizotifen and its side effects. Methodology: Descriptive cross-sectional study with 8 weeks of data collection. Data were collected at neurology clinic as an interviewer-administered validated questionnaire. Participants are identified with migraine and not previously prescribed with the preventive medication and patients were followed for 01 month. Likert scale,0-4 (0=No effect, 4= Severe), was used to collect data related to severity SEs score and total score for each patients’ SEs were calculated. Results: Of 270 migraine patients, 104 were selected and used both drugs. Prevalence of propranolol was 22% and 59 patients reported SEs (mean =2) which were palpitation (48%), postural hypotension (42%), dizziness (53%) and sleep disturbances (53%). And pizotifen prevalence was 17 %. 45 patients reported SE (mean=2.5) which were increase appetite (29%), dizziness (53%), drowsiness (27%), dry mouth (53%), nausea (56%), weight gain (7%) fatigue (29%) and prolonged sleep (13%). Pizotifen participants, dry mouth was significantly higher in male (p=0.025) and unemployed (p=0.038) and fatigue was higher in income below Rs.35,000.00 (p=0.026).Pizotifen had a significantly higher mean score (4.58) than propranolol (3.63), (p = 0.019). Conclusions: Pizotifen’s side-effects are more severe than propranolol. Clinical education on pizotifen side effects severity will improve awareness and adherence of the patients.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

